Thursday, 1 June 2017

Insilico Medicine launches a drug discovery platform ALS.AI

(InSilico Medicine, Inc.) Insilico Medicine with its collaborator, Above & Beyond, launched ALS.AI, launches the personalized drug discovery and biomarker development platform ALS.AI, utilizing the latest advances in deep learning.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2qErS2I

No comments:

Post a Comment